[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619-728-4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1067050, "exercisedValue": 0, "unexercisedValue": 7050750}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 49, "title": "Co-Founder & COO", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 737643, "exercisedValue": 0, "unexercisedValue": 4335961}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 627900, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 69, "title": "Chief Technology Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2024, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Senior VP of Corporate Development & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 59, "title": "Chief Development Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erik  Goluboff", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.17, "open": 10.34, "dayLow": 10.34, "dayHigh": 10.95, "regularMarketPreviousClose": 10.17, "regularMarketOpen": 10.34, "regularMarketDayLow": 10.34, "regularMarketDayHigh": 10.95, "payoutRatio": 0.0, "beta": 1.07, "forwardPE": -5.2227726, "volume": 192468, "regularMarketVolume": 192468, "averageVolume": 338319, "averageVolume10days": 378450, "averageDailyVolume10Day": 378450, "bid": 7.87, "ask": 13.27, "bidSize": 2, "askSize": 2, "marketCap": 561027904, "fiftyTwoWeekLow": 6.42, "fiftyTwoWeekHigh": 29.6, "fiftyDayAverage": 9.3962, "twoHundredDayAverage": 15.11005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 248206800, "profitMargins": 0.0, "floatShares": 15533291, "sharesOutstanding": 53178000, "sharesShort": 5101753, "sharesShortPriorMonth": 3935750, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0959, "heldPercentInsiders": 0.03688, "heldPercentInstitutions": 1.06468, "shortRatio": 17.61, "shortPercentOfFloat": 0.1407, "impliedSharesOutstanding": 53178000, "bookValue": 6.094, "priceToBook": 1.7312111, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -96436000, "trailingEps": -1.63, "forwardEps": -2.02, "enterpriseToEbitda": -2.193, "52WeekChange": -0.47250003, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 10.55, "targetHighPrice": 33.0, "targetLowPrice": 28.0, "targetMeanPrice": 30.14286, "targetMedianPrice": 30.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 318943008, "totalCashPerShare": 5.998, "ebitda": -113165000, "totalDebt": 6122000, "quickRatio": 22.515, "currentRatio": 22.783, "debtToEquity": 1.892, "returnOnAssets": -0.18996, "returnOnEquity": -0.27035, "freeCashflow": -37792624, "operatingCashflow": -73204000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1749249001, "regularMarketTime": 1749240000, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Tyra Biosciences, Inc.", "corporateActions": [], "regularMarketChangePercent": 3.73648, "regularMarketPrice": 10.55, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "shortName": "Tyra Biosciences, Inc.", "postMarketChangePercent": 11.564, "postMarketPrice": 11.77, "postMarketChange": 1.22, "regularMarketChange": 0.38, "regularMarketDayRange": "10.34 - 10.95", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 338319, "fiftyTwoWeekLowChange": 4.13, "fiftyTwoWeekLowChangePercent": 0.6433022, "fiftyTwoWeekRange": "6.42 - 29.6", "fiftyTwoWeekHighChange": -19.05, "fiftyTwoWeekHighChangePercent": -0.64358103, "fiftyTwoWeekChangePercent": -47.250004, "earningsTimestamp": 1746734705, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.63, "epsForward": -2.02, "epsCurrentYear": -2.09939, "priceEpsCurrentYear": -5.025269, "fiftyDayAverageChange": 1.1538, "fiftyDayAverageChangePercent": 0.12279432, "twoHundredDayAverageChange": -4.56005, "twoHundredDayAverageChangePercent": -0.3017892, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]